Majority of Claims in Zantac MDL Preempted by Federal Law, Fla. Judge Rules



DOCUMENTS
  • Order
  • Order


WEST PALM BEACH, Fla. — A Florida federal judge has dismissed a majority of the claims in the Zantac (ranitidine) multidistrict litigation, ruling that they are preempted by federal law because they seek to challenge the Food and Drug Administration-approved design and labeling of the drugs.

However, in the Dec. 31 order, Judge Robin L. Rosenberg of the U.S. District Court for the Southern District of Florida allowed the plaintiffs to amend their claims to the extent they are based upon allegations that defendants failed to transport the drugs at a temperature required by the label.

The judge also allowed …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Benzene Litigation - Using Genomics in the Courtroom

February 18, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: New Jersey Asbestos Litigation

February 11, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS